Who
Michael H. Carrel
Director
Company insider
Files Form 4 as: Director, Inspire Medical Systems; President, CEO, & Director, AtriCure; Director, Axonics; President & CEO, Vital Images.
In numbers
- Trades disclosed
- 279
- Buys
- 9
- Sells
- 33
- Bought
- $56K
- Sold
- $36.0M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 17 Jan 2006
- Last trade
- 14 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 16 Oct 2026 | INSP Inspire Medical SystemsMedical Devices | SEC FORM 4 Code A | $14K203 at $68.07 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —700 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —700 at $0.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 20 Jul 2026filed 27 Jul 2026 | INSP Inspire Medical SystemsMedical Devices | SEC FORM 4 Code A | —5,631 at $0.00 | filing |
| 20 Jul 2026filed 27 Jul 2026 | INSP Inspire Medical SystemsMedical Devices | SEC FORM 4 Code A | —5,631 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | $15K636 at $23.78 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | $15K636 at $23.78 | filing |
| 6 Mar 2026filed 9 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 6 Mar 2026filed 9 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 6 Mar 2026filed 9 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 6 Mar 2026filed 9 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —68,618 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —101,280 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $2.3M72,777 at $31.26 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —68,618 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —101,280 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $2.3M72,777 at $31.26 | filing |
| 10 Dec 2025filed 12 Dec 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Michael H. Carrel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.